Press Release: Celgene : Bristol Myers Squibb Announces Early Participation Results, Upsizing and Early Settlement of Tender Offers

Bristol-Myers Squibb Company (NYSE: BMY) ("Bristol Myers Squibb"), with its wholly-owned subsidiary Celgene Corporation ("Celgene") (collectively, the